Title: Measurement of open innovation through intellectual capital flows: framework and application

Authors: Francesca Michelino; Antonello Cammarano; Emilia Lamberti; Mauro Caputo

Addresses: Department of Industrial Engineering, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy ' Department of Industrial Engineering, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy ' Department of Enterprise Engineering, Università degli Studi di Roma Tor Vergata, Via del Politecnico, 1, 00133 Roma, Italy ' Department of Industrial Engineering, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, SA, Italy

Abstract: The paper suggests a methodology for measuring companies' openness degree through accounting data and providing a relation between open innovation activities and intellectual capital components. Four openness dimensions are defined and a synthetic measure of openness is suggested. The model is applied to a sample of 126 world top R&D spending companies in the bio-pharmaceutical industry for the period 2008-2012. Results show a negative correlation of openness with firm age, dimension and efficiency and a positive correlation with R&D intensity, with biotech companies being more open than pharmaceutical ones. Further, the most relevant component of openness is represented by the revenues deriving from joint development projects, out-licensing and R&D outsourcing. The paper contributes to the existing research by suggesting inbound and outbound metrics for open innovation and by underlining the role of intellectual capital. The framework can be used for monitoring and benchmarking the openness degree of companies with competitors.

Keywords: open innovation; inbound metrics; outbound metrics; accounting metrics; intellectual capital flows; human capital; structural capital; relational capital; intangible assets; biopharmaceutical industry; innovation measurement; R&D intensity; research and development; biotech companies; biotechnology; pharmaceutical industry; joint development projects; out-licensing; R&D outsourcing.

DOI: 10.1504/IJIE.2014.066679

International Journal of Intelligent Enterprise, 2014 Vol.2 No.2/3, pp.213 - 235

Received: 31 Dec 2013
Accepted: 16 Sep 2014

Published online: 14 Jan 2015 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article